同成医药 (837062.OC)

+ 收藏

财务摘要(报告期)(同成医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.04-0.26-0.131.180.89
 每股收益 - 稀释(元) 0.04-0.26-0.131.180.89
 每股收益 - 期末股本摊薄(元) 0.04-0.26-0.131.180.89
 每股净资产BPS(元) 4.524.464.594.724.43
 每股经营活动产生的现金流量净额(元) 1.000.22-0.170.750.18
 每股营业收入(元) 2.454.402.176.543.92
关键比率:
 净资产收益率 - 摊薄(%) 0.85-5.89-2.7625.0220.14
 净资产收益率 - 加权(%) --5.72-2.7227.9421.51
 净资产收益率 - 平均(%) 0.85-5.72-2.7227.9421.86
 净资产收益率 - 扣除(%) --5.98-2.7124.5019.64
 总资产净利率 - 平均(%) 0.28-2.24-1.1515.1212.96
 总资产报酬率ROA(%) 0.80-1.72-0.9717.3315.05
 投入资本回报率ROIC(%) 1.32-1.66-0.9120.9417.83
 销售毛利率(%) 10.976.617.8329.9732.90
 销售净利率(%) 1.57-5.97-5.8418.0522.76
 资产负债率(%) 66.1967.6162.7251.1843.32
 资产周转率(倍) 0.180.380.200.840.57
 销售商品提供劳务收到的现金/营业收入(%) 64.0969.6676.4075.5268.29
 营业利润同比增长率(%) 124.06-124.29-115.1714.9776.36
 营业收入同比增长率(%) 12.61-32.76-44.619.7237.56
 利润总额同比增长率(%) 122.03-124.91-115.5215.8975.51
 归属母公司股东的净利润同比增长率(%) 130.22-122.24-114.2118.7480.38
 扣非后归属母公司股东的净利润同比增长率(%) --123.06-114.3115.6078.30
 总资产同比增长率(%) 8.3742.4457.7362.3986.61
 总负债同比增长率(%) 14.3788.18128.38122.81268.02
 净资产同比增长率(%) -1.71-5.513.7426.4535.54
利润表摘要:
 营业总收入(元) 200,249,262.42360,125,194.02177,831,778.44535,550,337.68321,030,334.31
 营业总成本(元) 197,630,292.05378,796,846.02183,060,498.82430,437,711.11239,523,721.98
 营业收入(元) 200,249,262.42360,125,194.02177,831,778.44535,550,337.68321,030,334.31
 营业利润(元) 3,077,642.94-26,320,912.23-12,791,092.80108,364,271.3184,335,710.99
 利润总额(元) 2,874,729.02-26,911,527.63-13,049,649.48108,015,679.3684,081,716.95
 净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
 归属母公司股东的净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
 非经常性损益(元) -324,223.96-182,321.882,006,677.741,819,980.44
 归属母公司股东的净利润扣除非经常性损益(元) --21,824,105.25-10,195,894.4994,654,328.8771,234,728.12
资产负债表摘要:
 流动资产(元) 153,488,568.59173,807,152.60209,149,096.19182,532,859.84222,094,523.50
 固定资产(元) 369,447,816.40393,950,136.93355,304,187.11360,030,584.7864,362,197.22
 资产总计(元) 1,093,868,258.701,127,278,745.031,009,338,506.27791,428,117.23639,900,969.74
 流动负债(元) 641,557,127.88659,324,050.81470,413,700.75290,151,358.25245,825,250.14
 非流动负债(元) 82,515,221.27102,854,563.01162,681,197.98114,868,511.4531,384,556.01
 负债合计(元) 724,072,349.15762,178,613.82633,094,898.73405,019,869.70277,209,806.15
 股东权益(元) 369,795,909.55365,100,131.21376,243,607.54386,408,247.53362,691,163.59
 归属母公司股东的权益(元) 369,795,909.55365,100,131.21376,243,607.54386,408,247.53362,691,163.59
 资本公积(元) 5,021,292.355,021,292.355,021,292.355,021,292.355,021,292.35
 盈余公积(元) 37,652,292.5637,652,292.5637,652,292.5637,652,292.5628,073,137.64
 未分配利润(元) 231,215,005.34228,078,611.07239,200,275.99249,578,492.36235,551,349.23
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 128,344,631.26250,865,072.49135,869,542.69404,472,116.34219,243,832.58
 经营活动产生的现金净流量(元) 81,936,826.7418,048,916.20-13,748,193.3361,048,275.2314,784,636.60
 购建固定无形长期资产支付的现金(元) 12,451,861.16202,968,118.64135,089,907.39192,497,873.1357,584,694.55
 投资活动产生的现金净流量(元) -12,303,861.16-202,956,618.64-135,079,730.40-178,521,938.75-37,254,815.55
 取得借款收到的现金(元) 50,410,000.00287,485,540.00213,415,720.00204,755,000.0071,235,000.00
 筹资活动产生的现金净流量(元) -85,103,632.27169,896,362.46149,279,095.91129,065,520.8333,644,200.05
 现金及现金等价物净增加(元) -15,474,232.75-15,077,546.26596,084.6912,852,816.6211,889,415.81
 期末现金及现金等价物余额(元) 5,455,000.4720,929,233.2236,602,864.1736,006,779.4835,043,378.67
 折旧与摊销(元) 29,169,603.4053,334,957.7325,022,214.5625,155,933.791,186,570.32
公告日期 2024-08-232024-04-162023-08-282023-03-032022-08-19
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院